Fredun Pharmaceuticals Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Fredun Pharmaceuticals Ltd. on BSE

Load latest

Fredun Pharmaceuticals Ltd.

24 Apr 2024

701.00

4.85%

Board Meeting

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Intimation for Prior Intimation For The Board Meeting …

BSE India

Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/05/2024 ,inter alia, to consider and approve Notice is hereby given pursuant to Regulation 29 read with Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that the meeting of the Board of Directors of Fredun Pharmaceuticals Limited is scheduled to be held on Tuesday, 07th May, 2024 inter alia, to consider and approve the following: 1. Consider and approve Audited Financial Results for the Financial Year ended March 31, 2024 along with the Statement of Assets and Liabilities and Cash Flow statement as on that date. 2. Consider and recommend final dividend on the paid-up equity shares for the Financial Year ended March 31, 2024.

pdf

Fredun Pharmaceuticals Ltd.

15 Apr 2024

701.00

4.85%

Company Update

Fredun Pharmaceuticals Ltd - 539730 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Certificate under reg 74(5) of SEBI (DP) Reg, 2018

pdf

Fredun Pharmaceuticals Ltd.

15 Apr 2024

701.00

4.85%

Company Update

Fredun Pharmaceuticals Ltd - 539730 - Compliance Certificate For The Period Ended March 31, 2024

BSE India

Compliance certificate for the period ended March 31, 2024

pdf

Fredun Pharmaceuticals Ltd.

15 Apr 2024

701.00

4.85%

Corp. Note

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Outcome for Allotment Of 20,000 Equity Shares To …

BSE India

Allotment of 20,000 Equity Shares to Non-Promoter upon conversion of Warrants into Equity Shares

pdf

Fredun Pharmaceuticals Ltd.

30 Mar 2024

701.00

4.85%

SAST

Fredun Pharmaceuticals Ltd - 539730 - Closure of Trading Window

BSE India

Closure of Trading Window

pdf

Fredun Pharmaceuticals Ltd.

22 Mar 2024

701.00

4.85%

Corp. Note

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Outcome for Board Meeting Outcome For Allotment Of …

BSE India

This is to inform you that the Board of the Directors of the Company had pursuant to the approval of Shareholders in their Extra-Ordinary General Meeting held on September 23, 2022, has done allotment of convertible warrants on preferential basis to Non-promoters on March 22, 2024. Further, we would like to inform that the Warrant Holder have paid the balance of the consideration aggregating to Rs 12,45,250/- and have applied for exercising their rights for conversion of 2,500 warrants into equivalent number of equity Shares.

pdf

Fredun Pharmaceuticals Ltd.

14 Feb 2024

701.00

4.85%

Result

Fredun Pharmaceuticals Ltd - 539730 - Results- Outcome For The Board Meeting Dated 14.02.2024

BSE India

Results- Outcome for the Board Meeting dated 14.02.2024

pdf

Fredun Pharmaceuticals Ltd.

14 Feb 2024

701.00

4.85%

Board Meeting

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Outcome for Outcome For The Board Meeting Dated …

BSE India

We wish to inform you that the Board of Directors of Fredun Pharmaceuticals Limited (hereinafter referred to as 'the Company'), at their Meeting held on Wednesday, 14 February, 2024 had considered and approved the following item: 1. In compliance to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Un-Audited Financial Results of the Company for the Quarter and Nine months ended 31st December, 2023 along with the Limited Review Report as issued by M/s. R.H. Nisar & Co, Statutory Auditors of the Company; copies of which are attached hereunder; The Meeting of the Board Commenced at 02:00 P.M. and concluded at 07:00 P.M.

pdf

Fredun Pharmaceuticals Ltd.

12 Feb 2024

701.00

4.85%

Company Update

Fredun Pharmaceuticals Ltd - 539730 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release issued by Fredun Pharmaceuticals Limited

pdf

Fredun Pharmaceuticals Ltd.

05 Feb 2024

701.00

4.85%

Board Meeting

Fredun Pharmaceuticals Ltd - 539730 - Board Meeting Intimation for Board Meeting Of The Company On …

BSE India

Fredun Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 ,inter alia, to consider and approve To discuss, consider and approve Unaudited Financial Results of the Company for the Quarter and Nine Months ended 31St Decembers, 2023.

pdf

No results found

Is Fredun Pharmaceuticals Ltd. worth buying?

28 Votes:

Buy 67.86%

Sell 21.43%

Hold 10.71%

RESEARCH REPORTS

Not Rated SEE REPORTS >

pdf link